Power spectral density and similarity analysis of COVID-19 mortality waves across countries.

Heliyon

Instituto de Fisiología, Benemérita Universidad Autónoma de Puebla, 14 Sur 6301, Colonia San Manuel, Apartado Postal 406, CP 72570, Puebla, Puebla, Mexico.

Published: August 2024

Background: During the COVID-19 pandemic, the Johns Hopkins University Center for Systems Science and Engineering (CSSE) established a comprehensive database detailing daily mortality rates across countries. This dataset revealed fluctuating global mortality trends attributable to COVID-19; however, the specific differences and similarities in mortality patterns between countries remain insufficiently explored. Consequently, this study employs Fourier and similarity analyses to examine these patterns within the frequency domain, thereby offering novel insights into the dynamics of COVID-19 mortality waves across different nations.

Methods: We employed the Fast Fourier transform to calculate the power spectral density (PSD) of COVID-19 mortality waves in 199 countries from January 22, 2020, to March 9, 2023. Moreover, we performed a cosine similarity analysis of these PSD patterns among all the countries.

Results: We identified two dominant peaks in the grand averaged PSD: one at a frequency of 1.15 waves per year (i.e., one wave every 10.4 months) and another at 2.7 waves per year (i.e., one wave every 4.4 months). We also found a cosine similarity index distribution with a skewness of -0.54 and a global median of cosine similarity index of 0.84, thus revealing a remarkable similarity in the dominant peaks of the COVID-19 mortality waves.

Conclusion: These findings could be helpful for planetary health if a future pandemic of a similar scale occurs so that effective confinement measures or other actions could be planned during these two identified periods.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11336732PMC
http://dx.doi.org/10.1016/j.heliyon.2024.e35546DOI Listing

Publication Analysis

Top Keywords

covid-19 mortality
16
mortality waves
12
cosine similarity
12
power spectral
8
spectral density
8
similarity analysis
8
dominant peaks
8
waves year
8
year wave
8
mortality
7

Similar Publications

Severity and Long-Term Mortality of COVID-19, Influenza, and Respiratory Syncytial Virus.

JAMA Intern Med

January 2025

Research and Development, Veterans Affairs Puget Sound Health Care System, Seattle, Washington.

Importance: SARS-CoV-2, influenza, and respiratory syncytial virus (RSV) contribute to many hospitalizations and deaths each year. Understanding relative disease severity can help to inform vaccination guidance.

Objective: To compare disease severity of COVID-19, influenza, and RSV among US veterans.

View Article and Find Full Text PDF

Viremia defined as detectable SARS-CoV-2 RNA in the blood is a potential marker of disease severity and prognosis in COVID-19 patients. Here, we determined the frequency of viremia in serum of two independent COVID-19 patient cohorts within the German National Pandemic Cohort Network (German: tionales andemie horten etzwerk, NAPKON) with diagnostic RT-PCR against SARS-CoV-2. A cross-sectional cohort with 1,122 COVID-19 patients (German: , SUEP) and 299 patients recruited in a high-resolution platform with patients at high risk to develop severe courses (German: , HAP) were tested for viremia.

View Article and Find Full Text PDF

Background: Chest computed tomography (CT) is a valuable tool for diagnosing and predicting the severity of coronavirus disease 2019 (COVID-19) and assessing extrapulmonary organs. Reduced muscle mass and visceral fat accumulation are important features of a body composition phenotype in which obesity and muscle loss coexist, but their relationship with COVID-19 outcomes remains unclear. In this study, we aimed to investigate the association between the erector spinae muscle (ESM) to epicardial adipose tissue (EAT) ratio (ESM/EAT) on chest CT and disease severity in patients with COVID-19.

View Article and Find Full Text PDF

Background: Non-pharmaceutical interventions (NPIs) were widely used during the coronavirus disease 2019 (COVID-19) pandemic, however their impact on acute asthma exacerbations (AEs) is not well studied.

Methods: We had retrospectively collected patients with asthma AEs between 2019 and 2020 and retrieved data from the Chang Gung Research Database, including clinical manifestations, medications, pulmonary function, clinic and emergency department visits and hospitalizations.

Results: A total of 39,108 adult patients with asthma were enrolled, of whom 1502 were eligible for analysis.

View Article and Find Full Text PDF

Clinical characteristics and the role of IL-6 in acute-on-chronic liver failure patients with or without COVID-19: a multicenter paired cohort study.

Front Cell Infect Microbiol

January 2025

Department of Gastroenterology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China.

Background And Aims: The impact of coronavirus disease 2019 (COVID-19) on patients with acute-on-chronic liver failure (ACLF) remains unclear. To investigate the clinical characteristics of patients with ACLF complicated with COVID-19 in order to provide evidence for the precise treatment of this patient population.

Methods: A total of 34 ACLF patients with COVID-19 admitted to these three hospitals from December 2022 to August 2023 were included as the ACLF+COVID-19 group.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!